SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-14-080994
Filing Date
2014-11-14
Accepted
2014-11-14 16:31:03
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a14-23199_110q.htm 10-Q 917555
2 EX-31.1 a14-23199_1ex31d1.htm EX-31.1 12906
3 EX-31.2 a14-23199_1ex31d2.htm EX-31.2 12290
4 EX-32.1 a14-23199_1ex32d1.htm EX-32.1 7082
5 EX-32.2 a14-23199_1ex32d2.htm EX-32.2 7058
  Complete submission text file 0001104659-14-080994.txt   4920194

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT loxo-20140930.xml EX-101.INS 476594
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT loxo-20140930.xsd EX-101.SCH 36291
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT loxo-20140930_cal.xml EX-101.CAL 25563
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT loxo-20140930_def.xml EX-101.DEF 280072
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT loxo-20140930_lab.xml EX-101.LAB 650170
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT loxo-20140930_pre.xml EX-101.PRE 356050
Mailing Address 1 LANDMARK SQUARE, SUITE 1122 STAMFORD CT 06901
Business Address 1 LANDMARK SQUARE, SUITE 1122 STAMFORD CT 06901 203-658-4749
Loxo Oncology, Inc. (Filer) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36562 | Film No.: 141224697
SIC: 2834 Pharmaceutical Preparations